BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 2:47:00 PM | Browse: 380 | Download: 397
Publication Name World Journal of Cardiology
Manuscript ID 7584
Country of Manuscript Source Italy
2013-11-26 11:47
Peer-Review Started
2013-11-26 15:15
To Make the First Decision
2014-01-08 15:08
Return for Revision
2014-01-16 22:55
2014-01-22 23:36
Second Decision
2014-03-14 18:20
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-14 18:32
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-03-26 16:19
Typeset the Manuscript
2014-04-23 08:13
Publish the Manuscript Online
2014-04-24 19:19
ISSN 1949-8462 (online)
Open Access
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac and Cardiovascular Systems
Manuscript Type Topic Highlights
Article Title Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction
Manuscript Source Invited Manuscript
All Author List Chiara Lazzeri, Serafina Valente, Marco Chiostri, Maria Grazia D’Alfonso and Gian Franco Gensini
Funding Agency and Grant Number
Corresponding author Chiara Lazzeri, MD, Intensive Cardiac Care Unit, Heart and Vessel Department, Azienda Ospedaliero, Universitaria Careggi, Viale Morgagni 85, 50134 Florence, Italy. lazzeric@libero.it
Keywords Glycated hemoglobin; ST-elevation myocardial infarction; Prognosis; Hyperglycemia; Glucose intolerance
Core Tip Data on the prognostic role of glycated hemoglobin A1c (HbA1c) in patients with acute myocardial infarction (MI) are not univocal since they stem from studies which mainly differ in patients' selection criteria, therapy (thrombolysis vs mechanical revascularization) and number consistency. According to available evidence, in contemporary cohorts of ST-elevation myocardial infarction (STEMI) patients submitted to mechanical revascularization, HbA1c does not seem to be associated with short and long term mortality. However, in STEMI patients, HbA1c, even measured in the early phase, may represent a screening tool for glucose intolerance since its measurement can be performed in the non-fasting state and reflects average glucose concentration over the preceding 2-3 mo. We therefore proposed an algorithm based on pragmatic grounds which could be applied in STEMI patients without known diabetes in order to detect glucose intolerance abnormalities from the early phase. The main advantage of this algorithm is that it may help in tailoring the follow-up program, by helping in identifying patients at risk for the development of glucose intolerance after MI.
Publish Date 2014-04-24 19:19
Citation Lazzeri C, Valente S, Chiostri M, D'Alfonso MG, Gensini GF. Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. World J Cardiol 2014; 6(4): 140-147
Url http://www.wjgnet.com/1949-8462/full/v6/i4/140.htm
DOI http://dx.doi.org/10.4330/wjc.v6.i4.140
Full Article (PDF) WJC-6-140.pdf
Full Article (Word) WJC-6-140.doc
Manuscript File 7584-Review.doc
Answering Reviewers 7584-Answering reviewers.pdf
Copyright License Agreement 7584-Copyright assignment.pdf
Peer-review Report 7584-Peer review(s).pdf
Scientific Editor Work List 7584-Scientific editor work list.doc